Pfizer shareholders may finally get the bargain of their dreams in Seagen.

The cancer drug maker's innovative approach makes it an attractive acquisition candidate for a pharmaceutical behemoth. According to reports, pharmaceutical giant Pfizer Inc. is negotiating an acquisition that would please the company's investors. The Wall Street Journal reported last nig...